Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Pharm Dev Technol ; 26(9): 978-988, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34387136

RESUMEN

To cover the unpleasant taste of amoxicillin (250 mg), maize starch (baby food) and milk chocolate were co-formulated. The raw materials and the final formulations were characterized by means of Dynamic Light Scattering (DLS), Differential Scanning Calorimetry (DSC) and Fourier-Transform Infrared (FT-IR) spectroscopy. To evaluate the taste masking two different groups of volunteers were used, according to the Ethical Research Committee of the Aristotle University of Thessaloniki. The optimization of excipients' content in the tablet was determined by experimental design methodology (crossed D-optimal). Due to the matrix complexity, amoxicillin was extracted using liquid extraction and analyzed isocratically by HPLC. The developed chromatographic method was validated (%Recovery 98.7-101.3, %RSD = 1.3, LOD and LOQ 0.15 and 0.45 µg mL-1 respectively) according to the International Conference on Harmonization (ICH) guidelines. The physicochemical properties of the tablets were also examined demonstrating satisfactory quality characteristics (diameter: 15 mm, thickness: 6 mm, hardness <98 Newton, loss of mass <1.0%, disintegration time ∼25min). Additionally, dissolution (%Recovery >90) and in vitro digestion tests (%Recovery >95) were carried out. Stability experiments indicated that amoxicillin is stable in the prepared formulations for at least one year (%Recovery <91).


Asunto(s)
Amoxicilina/síntesis química , Antibacterianos/síntesis química , Química Farmacéutica/métodos , Composición de Medicamentos/métodos , Desarrollo de Medicamentos/métodos , Gusto/efectos de los fármacos , Administración Oral , Adolescente , Adulto , Amoxicilina/administración & dosificación , Amoxicilina/farmacocinética , Antibacterianos/administración & dosificación , Antibacterianos/farmacocinética , Aspartame/administración & dosificación , Aspartame/síntesis química , Aspartame/farmacocinética , Niño , Chocolate , Evaluación Preclínica de Medicamentos/métodos , Excipientes/administración & dosificación , Excipientes/síntesis química , Excipientes/farmacocinética , Femenino , Humanos , Masculino , Masticación/efectos de los fármacos , Masticación/fisiología , Comprimidos , Gusto/fisiología , Adulto Joven , Zea mays
2.
AAPS PharmSciTech ; 22(5): 183, 2021 Jun 16.
Artículo en Inglés | MEDLINE | ID: mdl-34132921

RESUMEN

The current study evaluated the effect of location and amount of various superdisintegrants on the properties of tablets made by twin-screw melt granulation (TSMG). Sodium-croscarmellose (CCS), crospovidone (CPV), and sodium starch glycolate (SSG) were used in various proportions intra- and extra-granular. Tabletability, compactibility, compressibility as well as friability, disintegration, and dissolution performance were assessed. The extra-granular addition resulted in the fasted disintegration and dissolution. CPV performed superior to CCS and SSG. Even if the solid fraction (SF) of the granules was lower for CPV, only a minor decrease in tabletability was observed, due to the high plastic deformation of the melt granules. The intra-granular addition of CPV resulted in a more prolonged dissolution profile, which could be correlated to a loss in porosity during tableting. The 100% intra-granular addition of the CPV resulted in a distinct decrease of the disintegration efficiency, whereas the performance of SSG was unaffected by the granulation process. CCS was not suitable to be used for the production of an immediate-release formulation, when added in total proportion into the granulation phase, but its efficiency was less impaired compared to CPV. Shortest disintegration (78 s) and dissolution (Q80: 4.2 min) was achieved with CPV extra-granular. Using CPV and CCS intra-granular resulted in increased disintegration time and Q80. However, at a higher level of appx. 500 s and appx. 15 min, only SSG showed a process and location independent disintegration and dissolution performance.


Asunto(s)
Carboximetilcelulosa de Sodio/síntesis química , Química Farmacéutica/métodos , Composición de Medicamentos/métodos , Povidona/síntesis química , Carboximetilcelulosa de Sodio/farmacocinética , Evaluación Preclínica de Medicamentos/métodos , Excipientes/síntesis química , Excipientes/farmacocinética , Excipientes Farmacéuticos/síntesis química , Excipientes Farmacéuticos/farmacocinética , Porosidad , Povidona/farmacocinética , Solubilidad , Comprimidos , Resistencia a la Tracción
3.
Pharm Dev Technol ; 26(6): 647-660, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33896355

RESUMEN

The aim of the current study was to achieve a dry powder formulation of vancomycin by spray drying whilst evaluating the effect of pH and excipient type and percentage used in formulation on particle characteristics and aerosolization performance. A D-optimal design was applied to optimize the formulation comprising vancomycin and two main excipient groups; a carbohydrate bulking agent (lactose, mannitol or trehalose) and a second excipient (hydroxypropyl beta-cyclodextrin or L-leucine) at pH 4 and 7. The physicochemical properties of particles (size, morphology, crystallinity state, residual moisture content), stability, and aerosolization characteristics were investigated. Using the combination of two excipients increased the fine particle fraction of powder emitted from an Aerolizer® device at a flow rate of 60 L/min. Hydroxypropyl beta-cyclodextrin showed more potential than L-leucine in aerosolization capabilities. Stability studies over 3 months of storage in 40 °C and 75% relative humidity suggested a good physical stability of the optimized formulation containing 17.39% hydroxypropyl beta-cyclodextrin along with 29.61% trehalose relative to the amount of drug at pH 4. Use of two excipients including trehalose and hydroxypropyl beta-cyclodextrin with a total weight ratio of 47% relative to the amount of drug is appropriate for the preparation of vancomycin dry powder formulation for inhalation.


Asunto(s)
Química Farmacéutica/métodos , Excipientes/síntesis química , Tamaño de la Partícula , Vancomicina/síntesis química , Administración por Inhalación , Evaluación Preclínica de Medicamentos/métodos , Inhaladores de Polvo Seco/métodos , Excipientes/administración & dosificación , Excipientes/análisis , Polvos , Vancomicina/administración & dosificación , Vancomicina/análisis , Difracción de Rayos X/métodos
4.
Pharm Biol ; 58(1): 561-573, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32615903

RESUMEN

Context: The Chinese medicinal materials originate from animals, plants, or minerals must undergo appropriate treatment before use as decoction pieces. Processing of Chinese medicines with liquid excipients is a pharmaceutical technique that transforms medicinal raw materials into decoction pieces which are significantly different from the original form. During processing, significant changes occur in chemical constituents, which inevitably affects clinical efficacy. At present, the liquid materials in processing mainly involve wine, vinegar, honey, saline water, ginger juice, herbal juice, etc.Objective: This review introduces the typical methods of liquid excipients processing, summarizes the influence on chemical composition, pharmacological efficacy, and expounds the ways and mechanisms of liquid excipients to change the properties of drugs, enhance the efficacy, eliminate or reduce toxicity and adverse reaction.Methods: English and Chinese literature from 1986 to 2020 was collected from databases including Web of Science, PubMed, Elsevier, Chinese Pharmacopoeia 2015, and CNKI (Chinese). Liquid excipients, processing, pharmacological effects, synergism, chemical constitution, traditional Chinese medicine (TCM) were used as the key words.Results: Liquid excipients play a key role in the application of TCM. Processing with proper liquid excipients can change the content of toxic or active components by physical or chemical transformation, decrease or increase drug dissolution, alter drug pharmacokinetics, or exert their own pharmacological effects. Thus, processing with liquid excipients is essential to ensure the safety and efficacy of TCM in clinic.Conclusion: This article could be helpful for researchers who are interested in traditional Chinese herbs processed with liquid excipients.


Asunto(s)
Medicamentos Herbarios Chinos/síntesis química , Excipientes/síntesis química , Medicina Tradicional China/métodos , Ácido Acético/síntesis química , Animales , Miel , Humanos , Medicina Tradicional China/tendencias , Aceites de Plantas/síntesis química , Vino
5.
AAPS PharmSciTech ; 20(4): 155, 2019 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-30924008

RESUMEN

In this paper, a novel formulation of dual-release dry suspension of mosapride citrate (DRDS-MC) was designed which can be quickly released in the stomach while having sustained-release effect. Co-grinding mixture of mosapride citrate (MC) together with L-HPC as hydrophilic excipient was prepared in order to improve the solubility of MC. The co-grinding mixture was characterized by solubility studies, DSC, X-RD, SEM, FTIR, and size distribution before the preparation of the DRDS-MC. Then, the co-grinding mixture was used to prepare DRDS-MC via wet granulation method. The evaluation of DRDS-MC was focused on physicochemical properties, intestinal absorption, and pharmacokinetics. The results of DSC, X-RD, SEM, FTIR, and size distribution indicated that MC resides in co-grinding mixture with no crystalline changes, hydrogen bonds made L-HPC greatly improving the solubility of MC. Then, the dissolution of DRDS-MC reached 70% in pH 1.2 within 2 h, and the 12-h dissolution of MC in pH 6.8 was nearly 80%. The sedimentation volume after 3 h was 0.94 and redispersibility was good. The linear regression equation between in vitro release of DRDS-MC and intestinal absorption fraction in rats was: Y = 29.215 + 47.535*X (r = 0.952). At last, pharmacokinetic studies in beagle dogs demonstrated that DRDS-MC has prolonged effect compared with commercial formulation Gasmotin as a reference. All results indicated that the DRDS-MC could be quickly released in the stomach while having sustained-release effect.


Asunto(s)
Benzamidas/síntesis química , Benzamidas/farmacocinética , Absorción Gastrointestinal/efectos de los fármacos , Fármacos Gastrointestinales/síntesis química , Fármacos Gastrointestinales/farmacocinética , Morfolinas/síntesis química , Morfolinas/farmacocinética , Animales , Estudios Cruzados , Preparaciones de Acción Retardada/síntesis química , Preparaciones de Acción Retardada/farmacocinética , Perros , Evaluación Preclínica de Medicamentos/métodos , Liberación de Fármacos/efectos de los fármacos , Liberación de Fármacos/fisiología , Excipientes/síntesis química , Excipientes/farmacocinética , Absorción Gastrointestinal/fisiología , Masculino , Distribución Aleatoria , Ratas , Solubilidad , Suspensiones
6.
Molecules ; 23(2)2018 Feb 03.
Artículo en Inglés | MEDLINE | ID: mdl-29401687

RESUMEN

The synthesis of two protected tetrasaccharide pentenyl glycosides with diarabinan and digalactan branching related to the pectic polysaccharide rhamnogalacturonan I is reported. The strategy relies on the coupling of N-phenyl trifluoroacetimidate disaccharide donors to a common rhamnosyl acceptor. The resulting trisaccharide thioglycosides were finally coupled to an n-pentenyl galactoside acceptor to access the two protected branched tetrasaccharides.


Asunto(s)
Técnicas de Química Sintética , Excipientes/síntesis química , Pectinas/síntesis química , Polisacáridos/síntesis química , Disacáridos/química , Portadores de Fármacos/síntesis química , Humanos , Imidoésteres/química , Tioglicósidos/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA